Development of therapeutics based on the Feldan Shuttle, a peptide-based delivery platform11-50 Employees
- B2B
- Growth StageExpanding market presence
- Recently fundedRaised funding in the past six months
- Website
- Location
- Company size
- 11-50 people
- Total raised
- $6M
- Company type
- Biotech
- Markets
Feldan Therapeutics careers
Feldan Therapeutics has developed a protein-based technology platform, the Feldan Shuttle, for direct delivery of proteins inside cells. The platform has been successfully used on several cell types (including human primary cells which are the center of most cell-based therapeutic applications) and allowed the transfer of active nucleases, transcription factors and antibodies. This platform can overcome delivery obstacles in the context of therapeutic use by providing a safe and highly efficient approach that alleviates manipulation complexity and that is associated with low regulatory burden. Also, preliminary results in rodents showed that the Feldan Shuttle could be potentially used in vivo.
Based on the fact that its technology has the potential to revolutionize the way that proteins are used in therapeutic applications, Feldan's mission is to develop regenerative medicine therapeutic applications based on the Feldan Shuttle platform.
Based on the fact that its technology has the potential to revolutionize the way that proteins are used in therapeutic applications, Feldan's mission is to develop regenerative medicine therapeutic applications based on the Feldan Shuttle platform.
Feldan Therapeutics hasn't added any jobs yet
Get notified when Feldan Therapeutics posts new jobs.
Francois-Thomas Michaud
Total raised
$6M
Funded over
1 round
Latest round
Seed (Apr 2017)
Quartzy • Houston • 3 weeks ago
Penumbra • Berlin • 3 weeks ago